Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion therapy in multiple sclerosis patients
IRCT20120302009188N2Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of bupropion in multiple sclerosis (MS), sponsored by Isfahan University of Medical Sciences. Started Oct 2019; status: completed.
02
Drugs
bupropion
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on IRCT20120302009188N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120302009188N2.